HIV Antibody Stems Infection in Clinical Trial (IMAGE)

American Association for the Advancement of Science (AAAS)

HIV Antibody Stems Infection in Clinical Trial

Caption

An early clinical trial shows that passive immunization with an HIV-1 neutralizing monoclonal antibody can help lower the amount of virus in the blood in HIV-1 infected subjects. This material relates to a paper that appeared in the Dec. 23, 2015 issue of Science Translational Medicine, published by AAAS. The paper, by R.M. Lynch at National Institute of Allergy and Infectious Diseases, National Institutes of Health in Bethesda, MD, and colleagues was titled, "Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection."

Credit

C. Bickel / <i>Science Translational Medicine</i>

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.